FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23965211000001100: Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78542201000001116 Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78542301000001113 Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Is a Trastuzumab emtansine 160mg powder for solution for infusion vials 1 vial true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has AMP Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient Trastuzumab emtansine false Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient Trastuzumab emtansine true Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start